Filter by:

Project name

Lead Institution



The aim of the study is to find out how many care home staff and residents have been infected with COVID-19, to inform decisions around the best approach to COVID-19 testing in the future.

Department of Health and Social Care, UK Health Security Agency 

King's College London
The key objective of the SOAP study is to address two main questions: (1) is there an immune signature of COVID19 which is specific to cancer patients; and (2) do recovered cancer patients carry a post-infection immunological legacy? 

Cancer Research UK (CRUK), King’s College London, Guy’s and St Thomas’ NHS Foundation NHS Trust , GSTT Charity, Blood Cancer UK and Leukaemia and Lymphoma Society (LLS)

Oxford University Hospital

The PREPARE project aims to understand the risk COVID-19 poses for patients with blood cancers using information from participants from the RUDY study. The first wave of the project will focus on myeloma patients who have joined the RUDY study.

Blood Cancer UK Research Collaborative

University of Glasgow

OCTAVE DUO, an extension of the OCTAVE trial, is investigating if a third vaccine dose for people with weakened immune systems gives a stronger immune response than two doses.

National Institute for Health Research (NIHR), UK Research and Innovation (UKRI)

University of Cambridge

This study will investigate the effect of obesity on COVID-19 vaccine effectiveness, as part of existing weight loss programmes in the obesity clinic in Cambridge University Hospital NHS Trust and King's College London.

UK Research and Innovation